Lamisil (Terbinafine Hydrochloride)

Terbinafine blocks the fungal enzyme squalene epoxidase, preventing the synthesis of ergosterol, an essential component of fungal cell membranes. This leads to toxic buildup of squalene and loss of membrane integrity, causing fungal cell death while sparing human cells.

The specific dosage and frequency of Lamisil cream are determined by the prescribing healthcare professional based on the infection type, severity, patient age and skin condition. Patients should follow the prescriber’s instructions and the product label.

Safety data for topical terbinafine during pregnancy and lactation are limited. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Lamisil.

To order Lamisil, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lamisil (terbinafine) belongs to the allylamine class, which typically offers rapid fungicidal activity and a shorter treatment course compared with azole antifungals. It is especially effective against dermatophytes, whereas some alternatives may be less potent for nail infections.

Lamisil cream should be stored at room temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture and direct sunlight, and keep it out of reach of children.

Apply a thin layer of Lamisil cream to the affected area once or twice daily, as directed by the prescriber. Gently rub the cream into clean, dry skin and wash hands after application, unless the hands are being treated.

Serious risks, though rare, include severe allergic reactions such as rash, swelling, or breathing difficulties, and systemic effects like liver enzyme elevation if significant absorption occurs. Patients should seek immediate medical attention if they experience any of these symptoms.

Lamisil should not be used on individuals with known hypersensitivity to terbinafine or any component of the formulation, on extensive broken skin, or on patients with severe liver disease without close monitoring. Children under two years of age should not use the product unless specifically advised by a physician.